• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜的唾液酸组、年龄相关性黄斑变性病理变化及其对补体因子H的潜在影响

The Sialome of the Retina, Alteration in Age-Related Macular Degeneration Pathology, and Potential Impacts on Complement Factor H.

作者信息

Swan Jaclyn, Toomey Christopher B, Bergstrand Max, Cuello Hector A, Robie Jesse, Yu Hai, Yuan Yue, Kooner Anoopjit Singh, Chen Xi, Shaughnessy Jutamas, Ram Sanjay, Varki Ajit, Gagneux Pascal

机构信息

Department of Pathology, University of California - San Diego, La Jolla, California, United States.

Shiley Eye Institute, Viterbi Family Department of Ophthalmology University of California - San Diego, La Jolla, California, United States.

出版信息

Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):81. doi: 10.1167/iovs.66.6.81.

DOI:10.1167/iovs.66.6.81
PMID:40576434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12212450/
Abstract

PURPOSE

Little is known about sialic acids of the human retina, despite their integral role in self /non-self-discrimination by complement factor H (FH), the alternative complement pathway inhibitor.

METHODS

A custom sialoglycan microarray was used to characterize the sialic acid-binding specificity of native FH or recombinant molecules where IgG Fc was fused to FH domains 16 to 20 (which contains a sialic acid-binding site), domains 6 and 7 (which contains a glycosaminoglycan-binding site), or the FH-related proteins (FHRs) 1 and 3. We analyzed macular and peripheral retinal tissue from postmortem ocular globes for the amount, type, and presentation (glycosidic linkage type) of sialic acid in individuals with age-related macular degeneration (AMD) and age-matched controls using fluorescent lectins and antibodies to detect sialic acid and endogenous FH. Released sialic acids from neural retina, retinal pigmented epithelium (RPE) cells, and the Bruch's membrane (BrM) were labeled with 1,2-diamino-4,5-methylenedioxybenzene-2HCl (DMB), separated and quantified by high-performance liquid chromatography (HPLC).

RESULTS

Both native FH and the recombinant FH domains 16 to 20 recognized Neu5Ac and Neu5Gc that is α2-3-linked to the underlying galactose. 4-O-Actylation of sialic acid and sulfation of GlcNAc did not inhibit binding. Different linkage types of sialic acid were localized at different layers of the retina. The greatest density of α2-3-sialic acid, which is the preferred ligand of FH, did not colocalize with endogenous FH. The level of sialic acids at the BrM/choroid interface of the macula and peripheral retina of individuals with AMD were significantly reduced.

CONCLUSIONS

The sialome of the human retina is altered in AMD. This may affect FH binding and, consequently, alternative complement pathway regulation.

摘要

目的

尽管唾液酸在补体因子H(FH,替代补体途径抑制剂)介导的自身/非自身识别中发挥着不可或缺的作用,但人们对人视网膜中的唾液酸却知之甚少。

方法

使用定制的唾液酸聚糖微阵列来表征天然FH或重组分子的唾液酸结合特异性,这些重组分子包括与FH结构域16至20(包含唾液酸结合位点)、结构域6和7(包含糖胺聚糖结合位点)融合的IgG Fc,或FH相关蛋白(FHRs)1和3。我们使用荧光凝集素和抗体来检测唾液酸和内源性FH,分析了来自死后眼球的黄斑和周边视网膜组织中,年龄相关性黄斑变性(AMD)患者和年龄匹配对照组的唾液酸含量、类型和呈现方式(糖苷键类型)。用1,2 - 二氨基 - 4,5 - 亚甲基二氧基苯 - 2HCl(DMB)标记从神经视网膜、视网膜色素上皮(RPE)细胞和布鲁赫膜(BrM)释放的唾液酸,通过高效液相色谱(HPLC)进行分离和定量。

结果

天然FH和重组FH结构域16至20均识别与下层半乳糖α2 - 3连接的Neu5Ac和Neu5Gc。唾液酸的4 - O - 乙酰化和GlcNAc的硫酸化不抑制结合。不同连接类型的唾液酸定位于视网膜的不同层。作为FH的首选配体的α2 - 3 - 唾液酸的最大密度区域与内源性FH不共定位。AMD患者黄斑和周边视网膜的BrM/脉络膜界面处的唾液酸水平显著降低。

结论

AMD患者的人视网膜唾液酸组发生改变。这可能影响FH结合,进而影响替代补体途径的调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/12212450/4d4c8d5ee719/iovs-66-6-81-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/12212450/7af18e201bbc/iovs-66-6-81-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/12212450/4db06ceb0e20/iovs-66-6-81-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/12212450/4d4c8d5ee719/iovs-66-6-81-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/12212450/7af18e201bbc/iovs-66-6-81-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/12212450/4db06ceb0e20/iovs-66-6-81-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb13/12212450/4d4c8d5ee719/iovs-66-6-81-f003.jpg

相似文献

1
The Sialome of the Retina, Alteration in Age-Related Macular Degeneration Pathology, and Potential Impacts on Complement Factor H.视网膜的唾液酸组、年龄相关性黄斑变性病理变化及其对补体因子H的潜在影响
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):81. doi: 10.1167/iovs.66.6.81.
2
The sialome of the retina, alteration in age-related macular degeneration (AMD) pathology and potential impacts on Complement Factor H.视网膜的唾液酸组、年龄相关性黄斑变性(AMD)病理变化及其对补体因子H的潜在影响
bioRxiv. 2025 Mar 13:2025.03.09.642149. doi: 10.1101/2025.03.09.642149.
3
Bruch's membrane heparan sulfate retains lipoproteins in the early stages of age-related macular degeneration.布鲁赫膜硫酸乙酰肝素在年龄相关性黄斑变性的早期阶段保留脂蛋白。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2500727122. doi: 10.1073/pnas.2500727122. Epub 2025 Jun 13.
4
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.用于保护黄斑健康的蓝光滤过型人工晶状体
Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2.
5
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
6
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.预防性使用非甾体抗炎药预防白内障手术后黄斑水肿。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
7
Surgery for cataracts in people with age-related macular degeneration.年龄相关性黄斑变性患者的白内障手术
Cochrane Database Syst Rev. 2017 Feb 16;2(2):CD006757. doi: 10.1002/14651858.CD006757.pub4.
8
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.光学相干断层扫描(OCT)用于检测糖尿病视网膜病变患者的黄斑水肿。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD008081. doi: 10.1002/14651858.CD008081.pub2.
9
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD006927. doi: 10.1002/14651858.CD006927.pub5.
10
A longitudinal study of the 5xFAD mouse retina delineates Amyloid beta (Aβ)-mediated retinal pathology from age-related changes.一项对5xFAD小鼠视网膜的纵向研究区分了淀粉样β蛋白(Aβ)介导的视网膜病变与年龄相关变化。
Alzheimers Res Ther. 2025 Jun 19;17(1):136. doi: 10.1186/s13195-025-01784-w.

引用本文的文献

1
Sialylation as a checkpoint for inflammatory and complement-related retinal diseases.唾液酸化作为炎症和补体相关视网膜疾病的一个检查点。
Front Cell Neurosci. 2025 Jun 27;19:1623755. doi: 10.3389/fncel.2025.1623755. eCollection 2025.

本文引用的文献

1
Decreased sialylation elicits complement-related microglia response and bipolar cell loss in the mouse retina.唾液酸化减少引起小鼠视网膜补体相关小胶质细胞反应和双极细胞丢失。
Glia. 2024 Dec;72(12):2295-2312. doi: 10.1002/glia.24613. Epub 2024 Sep 3.
2
Complement regulation in the eye: implications for age-related macular degeneration.补体调控与年龄相关性黄斑变性。
J Clin Invest. 2024 May 1;134(9):e178296. doi: 10.1172/JCI178296.
3
PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration.
聚唾液酸纳米颗粒激活补体因子H介导的替代补体途径抑制作用:一种针对年龄相关性黄斑变性的更安全潜在疗法。
Pharmaceuticals (Basel). 2024 Apr 17;17(4):517. doi: 10.3390/ph17040517.
4
Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials.多唾液酸修饰的免疫调节治疗性纳米颗粒(聚唾液酸纳米颗粒,PolySia-NPs)的全面眼及全身安全性评估,以支持进入首次人体临床试验。
Pharmaceuticals (Basel). 2024 Apr 9;17(4):481. doi: 10.3390/ph17040481.
5
Glycosylation Modulates the Structure and Functions of Collagen: A Review.糖基化修饰调节胶原的结构和功能:综述。
Molecules. 2024 Mar 22;29(7):1417. doi: 10.3390/molecules29071417.
6
PolySialic acid-nanoparticles inhibit macrophage mediated inflammation through Siglec agonism: a potential treatment for age related macular degeneration.聚唾液酸纳米颗粒通过 Siglec 激动剂抑制巨噬细胞介导的炎症:一种治疗年龄相关性黄斑变性的潜在方法。
Front Immunol. 2023 Nov 16;14:1237016. doi: 10.3389/fimmu.2023.1237016. eCollection 2023.
7
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.培格司他单抗治疗与年龄相关的黄斑变性(OAKS 和 DERBY)相关的地图状萎缩:两项多中心、随机、双盲、假对照、3 期临床试验。
Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9.
8
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.阿伐西普妥单抗治疗地图样萎缩患者的疗效和安全性(GATHER2):一项随机、双盲、3期试验的12个月结果
Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8.
9
Age-related macular degeneration: A disease of extracellular complement amplification.年龄相关性黄斑变性:一种细胞外补体放大疾病。
Immunol Rev. 2023 Jan;313(1):279-297. doi: 10.1111/imr.13145. Epub 2022 Oct 12.
10
Development and applications of sialoglycan-recognizing probes (SGRPs) with defined specificities: exploring the dynamic mammalian sialoglycome.具有明确特异性的唾液酸糖识别探针 (SGRP) 的开发和应用:探索动态哺乳动物唾液酸糖组。
Glycobiology. 2022 Nov 22;32(12):1116-1136. doi: 10.1093/glycob/cwac050.